Enterococcus faecium R0026 and Reduced Hyperlipidemia Symptoms

• Evaluation of Enterococcal Probiotic Usage and Review of Potential Health Benefits, Safety, and Risk of Antibiotic-Resistant Strain Emergence.

  • 2023-08-17
  • Review
  • Antibiotics (Basel, Switzerland) 12(8)
  • • Eric Jeeho Im
    • Harry Hyun-Yup Lee
    • Minzae Kim
    • Myo-Kyoung Kim

  • PubMed: 37627747
  • DOI: 10.3390/antibiotics12081327

  6 Insights on

  • Reduced Hyperlipidemia Symptoms

  • Low evidence

  studies that demonstrated the probiotic potential of enterococcal consumption (e.g., gastrointestinal and respiratory disease, hyperlipidemia alleviation, as well as infection prevention)

  Effect

  Beneficial

  Effect size

  Small

• Enterococcus faecium R0026 Combined with Bacillus subtilis R0179 Prevent Obesity-Associated Hyperlipidemia and Modulate Gut Microbiota in C57BL/6 Mice

  • 2021-02-28
  • RCT · n = 40
  • Journal of Microbiology and Biotechnology 31(2)
  • • Jinli Huang
    • Juan Huang
    • Tianyi Yin
    • Huiyun Lv
    • Pengyu Zhang
    • Huajun Li

  • PubMed: 33144552
  • DOI: 10.4014/jmb.2009.09005

  5 Insights on

  • Reduced Hyperlipidemia Symptoms

  • Low evidence
  • Animal Study

  LCBE significantly reduced the body weight gain, Lee index, brown fat index and body mass index of mice on a high-fat diet. Moreover, LCBE markedly improved serum lipids (including serum triglyceride, total cholesterol, low-density lipoprotein and highdensity lipoprotein) while also significantly reducing liver total cholesterol.

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes